Niagen Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	256	507	411	107	125	255
Market Cap Growth	-67.02%	23.47%	282.96%	-14.41%	-50.83%	-14.22%
Enterprise Value	192.37	445.01	368.61	83.17	109.09	231.27
Last Close Price	3.21	6.36	5.31	1.43	1.68	3.74
PE Ratio	15.28	31.80	48.27	-	-	-
Forward PE	16.89	27.81	50.28	160.00	160.00	160.00
PS Ratio	1.96	3.92	4.12	1.28	1.74	3.78
PB Ratio	3.10	6.62	8.91	3.77	4.37	8.03
P/TBV Ratio	3.57	7.67	9.07	3.84	4.18	8.14
P/FCF Ratio	62.40	38.37	34.37	15.39	-	-
P/OCF Ratio	57.87	37.54	33.91	15.07	-	-
EV/Sales Ratio	1.48	3.44	3.70	1.00	1.51	3.43
EV/EBITDA Ratio	16.06	33.98	43.16	-	-	-
EV/EBIT Ratio	17.33	36.14	47.71	-	-	-
EV/FCF Ratio	46.85	33.68	30.86	11.94	-	-
Debt / Equity Ratio	0.02	0.02	0.04	0.09	0.12	0.13
Debt / EBITDA Ratio	0.22	0.22	0.31	-	-	-
Debt / FCF Ratio	0.63	0.21	0.22	0.47	-	-
Net Debt / Equity Ratio	-0.78	-0.81	-0.91	-0.84	-0.56	-0.74
Net Debt / EBITDA Ratio	-5.34	-4.73	-4.92	5.26	0.92	0.91
Net Debt / FCF Ratio	-15.58	-4.69	-3.52	-3.45	1.05	0.96
Asset Turnover	1.18	1.48	1.62	1.53	1.29	1.40
Inventory Turnover	2.10	3.12	3.21	2.25	2.07	2.05
Quick Ratio	3.49	3.74	2.92	1.58	1.62	1.90
Current Ratio	4.61	4.86	3.57	2.40	2.61	2.78
Return on Equity (ROE)	21.24%	25.00%	25.97%	-17.29%	-54.77%	-112.68%
Return on Assets (ROA)	9.46%	13.39%	12.15%	-10.27%	-33.29%	-56.29%
Return on Invested Capital (ROIC)	63.45%	125.44%	176.38%	-66.28%	-180.00%	-565.55%
Return on Capital Employed (ROCE)	12.47%	18.00%	18.25%	-15.88%	-48.75%	-87.18%
Earnings Yield	7.27%	3.14%	2.07%	-	-	-
FCF Yield	1.60%	2.61%	2.91%	6.50%	-	-
Buyback Yield / Dilution	-7.04%	-9.36%	-4.19%	-7.54%	-3.79%	-10.02%
Total Shareholder Return	-7.04%	-9.36%	-4.19%	-7.54%	-3.79%	-10.02%

SEC Filings: 10-K · 10-Q